Trials / Sponsors / Laboratoire français de Fractionnement et de Biotechnologies

Laboratoire français de Fractionnement et de Biotechnologies

Industry · 16 registered clinical trials.

Status	Trial	Phase	Started
Terminated	A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Exce Hemophilia	Phase 3	2024-06-07
Completed	Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT® Hemophilia	—	2023-11-07
Completed	LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive Procedures Hemophilia	Phase 3	2016-08-25
Completed	A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa Hemophilia A With Inhibitors, Hemophilia B With Inhibitors	Phase 3	2015-12-07
Terminated	Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study Chronic Inflammatory Demyelinating Polyradiculoneuropathy	Phase 3	2015-11-01
Completed	Efficacy and Safety Study of I10E in Treatment of Patients With CIDP Chronic Inflammatory Demyelinating Polyradiculoneuropathy	Phase 3	2015-05-01
Completed	Fibrinogen in Haemorrhage of Delivery Post-Partum Hemorrhage	Phase 4	2014-04-10
Completed	Pharmacokinetics and Safety of Roledumab in RhD-negative Pregnant Women Carrying an RhD-positive Foetus Rh Disease	Phase 2	2014-04-01
Completed	Willebrand International Non-interventional Global Surveillance Von Willebrand Disease	—	2014-03-01
Completed	Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency Hypofibrinogenemia, Congenital, Afibrinogenemia, Congenital	Phase 2 / Phase 3	2014-01-01
Completed	LIME Study (LFB IVIg MMN Efficacy Study) Motor Neuron Disease	Phase 3	2013-12-01
Completed	Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home Alpha 1-Antitrypsin Deficiency	—	2012-01-01
Completed	Dose-finding Study of LFB-R593, A Monoclonal Anti-RhD Antibody, in Healthy RhD Negative Volunteers Healthy	Phase 2	2009-08-01
Completed	LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia	Phase 1	2008-11-01
Completed	Early Albumin Resuscitation During Septic Shock Septic Shock	Phase 4	2006-07-01
No Longer Available	HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Def Wound; Rupture, Surgery, Cesarean Section, Postpartum Hemorrhage, Surgery	—	—